Imaging phosphodiesterase-10a availability in cocaine use disorder with [11 C]IMA107 and PET
- PMID: 30240027
- PMCID: PMC6235703
- DOI: 10.1002/syn.22070
Imaging phosphodiesterase-10a availability in cocaine use disorder with [11 C]IMA107 and PET
Abstract
Phosphodiesterase-10a (PDE10a) is located exclusively in medium spiny neurons (MSN). Rodent studies show an increase in striatal MSN spine density following exposure to cocaine. These increases in MSN spine density are suggested to underlie neurobiological changes which contribute to cocaine self-administration. No postmortem or imaging studies have confirmed this finding in humans. Here, we hypothesized an increase in the MSN marker PDE10a in subjects with cocaine use disorder ("cocaine users") compared to controls. PDE10a availability was measured with [11 C]IMA107 and positron emission tomography in 15 cocaine users and 15 controls matched for age, gender, and nicotine status. Cocaine users with no comorbid psychiatric, medical, or drug abuse disorders were scanned following two weeks of outpatient-monitored abstinence. [11 C]IMA107 binding potential relative to nondisplaceable uptake (BPND ) in the regions of interest was derived with the simplified reference tissue method. No significant effect of diagnosis on BPND was demonstrated using linear mixed modeling with [11 C]IMA107 BPND as the dependent variable and regions of interest as a repeated measure. There were no significant relationships between BPND and clinical rating scales. To the extent that PDE10a is a valid proxy for MSN spine density, these results do not support its increase in recently abstinent cocaine users.
Keywords: [11C]IMA107; cocaine use disorders; medium spiny neurons; phosphodiesterase-10a (PDE 10a); positron emission tomography.
© 2018 Wiley Periodicals, Inc.
References
-
- Ahmad R, Bourgeois S, Postnov A, Schmidt ME, Bormans G, Van Laere K, Vandenberghe W. 2014. PET imaging shows loss of striatal PDE10A in patients with Huntington disease. Neurology 82(3):279–281. - PubMed
-
- Collins DZ AP ; Kollokian V ; Sled JG ; Kabani NJ ; Holmes CJ ; Evans AC. 1998. Design and construction of a realistic digital brain phantom. IEEE Transactions on Medical Imaging 17(3):463–468. - PubMed
-
- Douaud G GV, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P et al. 2006. Distribution of grey matter atrophy in Huntington’s disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 32(4):1562–1575. - PubMed
-
- Fazio P, Schain M, Mrzljak L, Amini N, Nag S, Al-Tawil N, Fitzer-Attas CJ, Bronzova J, Landwehrmeyer B, Sampaio C, Halldin C, Varrone A. 2017. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with (18)F-MNI-659 and (11)C-raclopride with correction for partial volume effect. Neuroimage 152:330–339. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous